Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gregory Schwartz

Concepts (518)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
71
2024
264
16.530
 Why?
Anticholesteremic Agents
52
2024
146
12.690
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
56
2024
429
8.070
 Why?
Lipoprotein(a)
21
2025
66
7.670
 Why?
Antibodies, Monoclonal, Humanized
40
2025
755
6.810
 Why?
Cholesterol, LDL
51
2025
349
6.430
 Why?
Myocardial Infarction
44
2023
1018
5.210
 Why?
Cardiovascular Diseases
39
2024
1997
4.490
 Why?
Proprotein Convertase 9
25
2024
68
3.550
 Why?
Coronary Disease
16
2020
380
3.230
 Why?
Angina, Unstable
19
2019
75
2.920
 Why?
Heptanoic Acids
23
2016
63
2.750
 Why?
Diabetes Mellitus, Type 2
23
2025
2421
2.740
 Why?
Cholesterol, HDL
13
2020
197
2.730
 Why?
Sulfhydryl Compounds
10
2020
187
2.580
 Why?
Pyrroles
23
2016
201
2.560
 Why?
Hypercholesterolemia
11
2023
101
2.530
 Why?
Stroke
31
2023
1071
2.490
 Why?
Dyslipidemias
8
2024
173
2.390
 Why?
Quinazolinones
7
2021
19
2.230
 Why?
Serine Proteinase Inhibitors
4
2024
42
1.760
 Why?
Myocardial Ischemia
17
2018
259
1.690
 Why?
Secondary Prevention
11
2019
220
1.660
 Why?
Thiazolidinediones
10
2017
137
1.630
 Why?
Atherosclerosis
11
2024
402
1.620
 Why?
Cholesterol
12
2022
399
1.610
 Why?
Double-Blind Method
42
2024
1873
1.600
 Why?
Treatment Outcome
63
2024
10232
1.480
 Why?
Esters
9
2020
74
1.430
 Why?
Amides
9
2020
91
1.420
 Why?
Oxazoles
8
2019
30
1.400
 Why?
Hypoglycemic Agents
18
2024
1219
1.390
 Why?
Cholesterol Ester Transfer Proteins
5
2016
18
1.360
 Why?
Risk Factors
45
2024
9779
1.350
 Why?
Thiophenes
8
2019
117
1.320
 Why?
Aged
76
2025
22063
1.290
 Why?
Middle Aged
80
2025
31087
1.210
 Why?
Myocardial Contraction
14
2013
334
1.200
 Why?
Ventricular Fibrillation
3
2017
57
1.190
 Why?
Humans
163
2025
129527
1.190
 Why?
Coronary Artery Disease
6
2023
677
1.160
 Why?
Risk Assessment
20
2024
3255
1.150
 Why?
Insulin Resistance
10
2018
1168
1.140
 Why?
Swine
34
2017
760
1.140
 Why?
C-Reactive Protein
11
2022
400
1.130
 Why?
Antibodies, Monoclonal
7
2023
1366
1.120
 Why?
Metabolic Syndrome
4
2013
335
1.080
 Why?
Myocardium
23
2004
981
1.070
 Why?
Diabetic Angiopathies
2
2019
256
1.050
 Why?
Male
100
2025
63586
1.040
 Why?
Female
109
2025
68650
0.990
 Why?
Myocardial Reperfusion Injury
5
2013
129
0.970
 Why?
Ischemic Attack, Transient
6
2018
60
0.960
 Why?
Heart
10
2009
643
0.920
 Why?
Lipoproteins, HDL
4
2019
74
0.920
 Why?
Proteins
3
2020
944
0.910
 Why?
PPAR gamma
6
2022
183
0.900
 Why?
Peripheral Arterial Disease
3
2020
458
0.870
 Why?
Proprotein Convertases
2
2014
15
0.860
 Why?
RNA, Small Interfering
10
2024
590
0.840
 Why?
Triglycerides
5
2024
514
0.810
 Why?
Fatty Acids, Nonesterified
4
2018
159
0.740
 Why?
Insulin
7
2021
2313
0.740
 Why?
Patient Admission
2
2021
183
0.730
 Why?
Time Factors
21
2024
6530
0.720
 Why?
Biomarkers
20
2024
3968
0.720
 Why?
Coronary Circulation
18
2004
138
0.700
 Why?
Hospitalization
5
2019
2076
0.690
 Why?
Randomized Controlled Trials as Topic
18
2024
1368
0.680
 Why?
Molecular Targeted Therapy
2
2014
391
0.680
 Why?
Cardiovascular Agents
4
2021
157
0.680
 Why?
Recurrence
11
2021
1011
0.650
 Why?
Energy Metabolism
13
2004
864
0.620
 Why?
Swine, Miniature
3
2013
81
0.580
 Why?
Lipid Metabolism
2
2014
500
0.580
 Why?
Adiponectin
2
2018
236
0.580
 Why?
Heart Arrest
4
2017
323
0.580
 Why?
Venous Thrombosis
1
2020
176
0.570
 Why?
Brain Ischemia
5
2022
321
0.570
 Why?
Ezetimibe
4
2023
24
0.560
 Why?
Aldosterone
1
2017
43
0.530
 Why?
Rosuvastatin Calcium
4
2022
20
0.520
 Why?
Cardiovascular System
1
2018
136
0.520
 Why?
Venous Thromboembolism
1
2020
287
0.500
 Why?
Patient Readmission
2
2021
667
0.470
 Why?
Arteriosclerosis
2
2014
85
0.460
 Why?
Renal Insufficiency, Chronic
4
2024
566
0.460
 Why?
Adenosine Triphosphate
14
2017
475
0.450
 Why?
Drug Therapy, Combination
6
2020
1037
0.440
 Why?
Magnetic Resonance Spectroscopy
17
2019
541
0.430
 Why?
Metformin
1
2017
316
0.420
 Why?
Diabetes Complications
3
2021
219
0.420
 Why?
Veterans
3
2023
1382
0.410
 Why?
Phosphocreatine
13
1995
43
0.400
 Why?
Atrial Fibrillation
2
2022
376
0.400
 Why?
Hyperlipoproteinemia Type II
2
2024
31
0.400
 Why?
Animals
46
2017
35334
0.390
 Why?
Phosphates
7
2024
181
0.390
 Why?
Heart Failure
9
2022
2143
0.390
 Why?
Hemodynamics
11
2007
1094
0.390
 Why?
Proportional Hazards Models
9
2019
1196
0.390
 Why?
Ventricular Function, Left
9
2004
529
0.380
 Why?
Obesity
3
2024
2875
0.380
 Why?
Blood Pressure
11
2012
1735
0.380
 Why?
Coronary Vessels
8
2012
239
0.380
 Why?
Dietary Fats
2
2013
298
0.370
 Why?
Uncertainty
1
2012
122
0.370
 Why?
Follow-Up Studies
11
2023
4891
0.350
 Why?
Drug Administration Schedule
8
2019
763
0.350
 Why?
Glucose
5
2020
996
0.350
 Why?
Reperfusion Injury
2
2005
272
0.340
 Why?
Systole
7
2001
190
0.340
 Why?
Fluorobenzenes
2
2014
15
0.340
 Why?
Research Design
3
2009
1043
0.330
 Why?
Risk
9
2018
857
0.330
 Why?
Phospholipases A2, Secretory
4
2014
12
0.330
 Why?
Diastole
5
2001
148
0.310
 Why?
Ischemia
1
2012
405
0.310
 Why?
Ventricular Dysfunction, Right
3
2007
231
0.310
 Why?
Surgical Procedures, Operative
4
2017
242
0.290
 Why?
Cohort Studies
6
2023
5423
0.290
 Why?
KATP Channels
1
2008
20
0.290
 Why?
Apolipoproteins B
5
2022
43
0.290
 Why?
Mortality
3
2017
306
0.280
 Why?
Clinical Trials, Phase III as Topic
3
2024
94
0.280
 Why?
Acute Disease
9
2012
975
0.280
 Why?
Chromans
3
2004
24
0.280
 Why?
Hypolipidemic Agents
3
2022
88
0.280
 Why?
Incidence
7
2022
2643
0.280
 Why?
Survival Analysis
7
2018
1270
0.270
 Why?
Dose-Response Relationship, Drug
7
2019
2013
0.270
 Why?
Veterans Health
2
2020
179
0.270
 Why?
Prognosis
6
2024
3772
0.260
 Why?
Cholecalciferol
1
2007
56
0.260
 Why?
Pyrimidines
2
2014
458
0.260
 Why?
Sulfonamides
2
2014
497
0.260
 Why?
Phospholipids
3
2018
215
0.250
 Why?
Subtilisins
2
2023
10
0.250
 Why?
Fenofibrate
1
2005
29
0.250
 Why?
Myelodysplastic Syndromes
1
2007
129
0.240
 Why?
Disease Models, Animal
8
2013
4073
0.240
 Why?
Dobutamine
5
2000
37
0.240
 Why?
Blood Glucose
6
2024
2071
0.240
 Why?
Oxygen Consumption
8
2000
663
0.240
 Why?
Acetates
3
2019
100
0.230
 Why?
Apolipoprotein A-I
2
2018
28
0.230
 Why?
Natriuretic Peptide, Brain
3
2024
99
0.230
 Why?
Prediabetic State
2
2020
244
0.230
 Why?
Adrenergic beta-Antagonists
3
2013
320
0.220
 Why?
Cardiotonic Agents
3
2005
126
0.220
 Why?
Lanthanum
1
2024
13
0.220
 Why?
Morbidity
5
2017
300
0.220
 Why?
Hyperemia
3
1991
48
0.220
 Why?
Cause of Death
5
2017
395
0.220
 Why?
Syndrome
6
2007
338
0.220
 Why?
Lipids
3
2024
614
0.210
 Why?
Injections, Subcutaneous
2
2024
146
0.210
 Why?
Thiazoles
2
2003
118
0.210
 Why?
Phosphorylation
3
2013
1714
0.210
 Why?
Serine Endopeptidases
2
2014
118
0.200
 Why?
Isoproterenol
3
1998
116
0.200
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
15
0.200
 Why?
Blood Vessels
1
2024
184
0.200
 Why?
Indoles
3
2019
387
0.200
 Why?
Predictive Value of Tests
5
2017
1950
0.190
 Why?
Propensity Score
2
2021
266
0.190
 Why?
Insulin Receptor Substrate Proteins
2
2013
59
0.180
 Why?
Pancreatic Neoplasms
2
2000
875
0.180
 Why?
Diacetyl
1
2001
6
0.180
 Why?
PPAR alpha
4
2022
58
0.180
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
216
0.180
 Why?
Cost-Benefit Analysis
2
2020
566
0.180
 Why?
Muscles
1
2022
320
0.180
 Why?
Peptide Fragments
3
2024
695
0.180
 Why?
Residence Characteristics
2
2016
331
0.180
 Why?
Mental Status and Dementia Tests
1
2021
22
0.180
 Why?
Cytokines
2
2005
2018
0.170
 Why?
Apolipoproteins
3
2012
32
0.170
 Why?
Myocardial Reperfusion
1
2000
50
0.170
 Why?
Cataract
1
2023
208
0.170
 Why?
Coronary Artery Bypass
2
2019
224
0.170
 Why?
Perioperative Care
2
2017
165
0.170
 Why?
Lipoproteins, LDL
2
2014
117
0.160
 Why?
Calpain
2
2012
57
0.160
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
92
0.160
 Why?
Matrix Metalloproteinases
1
2000
91
0.160
 Why?
Cadmium
1
2000
67
0.160
 Why?
Sodium
1
2020
204
0.160
 Why?
Potassium
1
2000
144
0.160
 Why?
Oncogenes
1
2000
110
0.160
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
260
0.160
 Why?
Proto-Oncogene Proteins c-akt
2
2013
427
0.150
 Why?
United States
7
2023
13865
0.150
 Why?
Renin-Angiotensin System
1
2019
82
0.150
 Why?
Alkaline Phosphatase
1
2019
146
0.150
 Why?
Multifactorial Inheritance
1
2019
150
0.150
 Why?
Adenylyl Cyclases
2
2016
83
0.150
 Why?
Early Termination of Clinical Trials
2
2015
15
0.150
 Why?
Immunoturbidimetry
1
2018
1
0.150
 Why?
Calcifediol
1
1998
31
0.150
 Why?
Risk Reduction Behavior
1
2020
209
0.150
 Why?
Carotid Artery Diseases
1
2018
64
0.150
 Why?
Collagen
1
2000
436
0.140
 Why?
Adrenergic beta-Agonists
1
1998
133
0.140
 Why?
Calcitriol
1
1998
54
0.140
 Why?
American Heart Association
1
2019
300
0.140
 Why?
Oxidative Stress
1
2024
1261
0.140
 Why?
Aged, 80 and over
8
2020
7052
0.140
 Why?
Citrate (si)-Synthase
1
2017
58
0.140
 Why?
Global Health
2
2017
328
0.130
 Why?
Pharmacogenetics
2
2016
172
0.130
 Why?
Prostate
1
1998
170
0.130
 Why?
Hypertension, Pulmonary
3
2012
1891
0.130
 Why?
Postoperative Complications
2
2019
2475
0.130
 Why?
Percutaneous Coronary Intervention
2
2019
467
0.130
 Why?
Prostatic Neoplasms
3
1998
995
0.130
 Why?
Australia
4
2019
242
0.130
 Why?
Administration, Intravenous
1
2017
142
0.130
 Why?
Inflammation
6
2016
2741
0.130
 Why?
Drug Design
1
2017
157
0.130
 Why?
Lipoproteins
2
2014
161
0.130
 Why?
Signal Transduction
1
2009
4916
0.130
 Why?
Simvastatin
2
2015
60
0.130
 Why?
Inflammation Mediators
2
2013
503
0.130
 Why?
Clinical Trials as Topic
2
2018
1001
0.130
 Why?
Epigenesis, Genetic
1
2021
617
0.130
 Why?
Anti-Arrhythmia Agents
2
2012
112
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
190
0.120
 Why?
Platelet Aggregation Inhibitors
1
2019
441
0.120
 Why?
Heart Ventricles
6
2012
778
0.120
 Why?
ATP Binding Cassette Transporter 1
1
2015
10
0.120
 Why?
Diet
2
2013
1211
0.120
 Why?
Hospital Mortality
1
2019
851
0.120
 Why?
Vasodilation
2
2013
476
0.120
 Why?
Recombinant Proteins
1
2018
1311
0.120
 Why?
Transcription Factors
1
2003
1642
0.120
 Why?
Chromosomes, Human, Pair 16
1
2015
30
0.120
 Why?
Environment
1
2016
345
0.110
 Why?
Smoking
2
2000
1501
0.110
 Why?
Homeostasis
1
2018
605
0.110
 Why?
Stents
1
2018
504
0.110
 Why?
Linkage Disequilibrium
1
2015
257
0.110
 Why?
Serum Amyloid A Protein
3
2013
31
0.110
 Why?
Endovascular Procedures
1
2018
301
0.110
 Why?
Disease Progression
4
2018
2628
0.110
 Why?
Heart Rate
5
2001
804
0.110
 Why?
Phospholipases A
1
2014
98
0.110
 Why?
Fasting
1
2015
265
0.110
 Why?
Mendelian Randomization Analysis
1
2013
47
0.100
 Why?
Adult
12
2024
35505
0.100
 Why?
Acyl Coenzyme A
1
2013
31
0.100
 Why?
Heart Function Tests
1
2013
59
0.100
 Why?
Ultraviolet Rays
2
1992
383
0.100
 Why?
Ventricular Function, Right
1
1995
276
0.100
 Why?
Retrospective Studies
6
2018
14532
0.100
 Why?
Hydroxy Acids
1
2012
4
0.100
 Why?
Decanoic Acids
1
2012
8
0.100
 Why?
Ischemic Preconditioning, Myocardial
1
2012
30
0.100
 Why?
Talin
1
2012
8
0.100
 Why?
Cardiolipins
1
2013
83
0.100
 Why?
Potassium Channel Blockers
1
2012
36
0.100
 Why?
Glyburide
1
2012
32
0.100
 Why?
Nitric Oxide Synthase Type III
1
2013
201
0.100
 Why?
Case-Control Studies
1
2019
3383
0.100
 Why?
Europe
3
2019
362
0.100
 Why?
North America
3
2019
294
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
22
0.090
 Why?
Prospective Studies
2
2021
7150
0.090
 Why?
Polymorphism, Genetic
1
2015
636
0.090
 Why?
Practice Guidelines as Topic
1
2019
1510
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
DNA
2
2013
1400
0.090
 Why?
Tissue Plasminogen Activator
2
2013
222
0.090
 Why?
Arteries
1
2013
266
0.090
 Why?
Hypertension
1
2000
1235
0.090
 Why?
Death, Sudden, Cardiac
1
2012
179
0.090
 Why?
MAP Kinase Signaling System
1
2013
312
0.090
 Why?
Electrocardiography
3
2011
612
0.090
 Why?
Fractures, Bone
1
2016
395
0.090
 Why?
Myocardial Revascularization
3
2017
71
0.080
 Why?
Prejudice
1
2011
70
0.080
 Why?
United States Department of Veterans Affairs
3
2016
628
0.080
 Why?
Phosphorus
5
1995
92
0.080
 Why?
Down-Regulation
2
2024
631
0.080
 Why?
RNA, Messenger
3
2015
2697
0.080
 Why?
Gene Expression Regulation
2
2013
2544
0.080
 Why?
Age Factors
3
2011
3150
0.080
 Why?
Neoplasms
1
2023
2450
0.080
 Why?
Macrophages
1
2016
1486
0.070
 Why?
Vitamin D Deficiency
1
1990
177
0.070
 Why?
MicroRNAs
1
2015
677
0.070
 Why?
Vascular Diseases
2
2022
240
0.070
 Why?
Diabetes Mellitus
1
2016
988
0.070
 Why?
Ventricular Pressure
1
2007
45
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
353
0.070
 Why?
Models, Biological
1
2014
1717
0.070
 Why?
Ultrasonography, Interventional
2
2018
130
0.070
 Why?
Kaplan-Meier Estimate
2
2020
850
0.070
 Why?
Survival Rate
1
2011
1870
0.070
 Why?
Angiomatosis
1
2006
4
0.060
 Why?
Reactive Oxygen Species
1
2009
591
0.060
 Why?
Hemangioma, Capillary
1
2006
13
0.060
 Why?
Lactic Acid
2
1998
304
0.060
 Why?
Angina Pectoris
2
2004
66
0.060
 Why?
Anti-Inflammatory Agents
1
2009
481
0.060
 Why?
Ultrasonography
1
2009
708
0.060
 Why?
Cerebrovascular Disorders
2
2017
90
0.060
 Why?
Liver
2
2024
1836
0.060
 Why?
Chronic Disease
1
2011
1722
0.060
 Why?
Sus scrofa
1
2004
46
0.060
 Why?
alpha-Tocopherol
1
2004
33
0.060
 Why?
Administration, Oral
1
2007
783
0.060
 Why?
Arterial Occlusive Diseases
2
1982
80
0.060
 Why?
Linear Models
2
2013
818
0.060
 Why?
CD40 Ligand
1
2004
38
0.060
 Why?
Antigen-Antibody Complex
1
2004
86
0.060
 Why?
Least-Squares Analysis
1
2004
78
0.060
 Why?
Multicenter Studies as Topic
2
2012
287
0.050
 Why?
Economics, Pharmaceutical
1
2003
9
0.050
 Why?
Muscular Diseases
1
2004
109
0.050
 Why?
Regional Blood Flow
3
1996
464
0.050
 Why?
Comorbidity
2
2019
1548
0.050
 Why?
Guidelines as Topic
1
2005
261
0.050
 Why?
Lactates
2
1994
85
0.050
 Why?
Death
2
2019
116
0.050
 Why?
Creatine Kinase
1
2022
75
0.050
 Why?
Pharmacogenomic Testing
1
2022
61
0.050
 Why?
Multivariate Analysis
2
2017
1491
0.050
 Why?
Verapamil
1
2001
41
0.040
 Why?
Goals
1
2022
163
0.040
 Why?
Antioxidants
1
2004
557
0.040
 Why?
Organ Preservation Solutions
1
2001
45
0.040
 Why?
Oxidation-Reduction
3
2012
1029
0.040
 Why?
Receptors, Immunologic
1
2022
216
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Ventricular Dysfunction
1
2000
15
0.040
 Why?
Myocardial Stunning
1
2000
5
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
17
0.040
 Why?
Collagenases
1
2000
24
0.040
 Why?
Health Care Costs
1
2003
366
0.040
 Why?
Hexamethonium
1
2000
4
0.040
 Why?
Arrhythmias, Cardiac
1
2003
321
0.040
 Why?
Atropine
1
2000
24
0.040
 Why?
Liver Cirrhosis
1
2022
281
0.040
 Why?
Interleukin-6
3
2013
724
0.040
 Why?
Dilatation, Pathologic
1
2000
60
0.040
 Why?
Louisiana
1
2000
27
0.040
 Why?
Dipeptides
2
2012
48
0.040
 Why?
Occupations
1
2000
42
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
123
0.040
 Why?
Cell Line
2
2016
2774
0.040
 Why?
Pericardium
1
2000
54
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
385
0.040
 Why?
Blood Chemical Analysis
1
2020
97
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
72
0.040
 Why?
Antigens, CD
1
2022
485
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
Placebo Effect
1
2019
55
0.040
 Why?
New Zealand
1
2019
45
0.040
 Why?
Logistic Models
1
2004
1983
0.040
 Why?
Insulin Antagonists
1
1998
7
0.040
 Why?
Ventricular Function
1
1999
61
0.040
 Why?
Sex Characteristics
1
2024
734
0.040
 Why?
Hormone Antagonists
1
1998
33
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Drug Combinations
1
2000
329
0.040
 Why?
Somatostatin
1
1998
56
0.040
 Why?
India
1
2019
171
0.040
 Why?
Placebos
1
2019
200
0.040
 Why?
Pulmonary Artery
2
2006
1075
0.040
 Why?
Israel
1
2018
48
0.040
 Why?
Infusion Pumps
1
2018
32
0.040
 Why?
Microscopy, Electron
1
1999
423
0.040
 Why?
Netherlands
1
2018
77
0.040
 Why?
Florida
1
1998
93
0.040
 Why?
Elasticity
1
1999
193
0.040
 Why?
Protective Factors
1
2018
91
0.040
 Why?
Vitamin D
2
1992
379
0.040
 Why?
Sex Factors
1
2024
1966
0.040
 Why?
Drug Interactions
1
2019
397
0.040
 Why?
Blood Flow Velocity
1
1999
406
0.030
 Why?
Echocardiography, Transesophageal
1
1997
93
0.030
 Why?
Selection Bias
1
2017
37
0.030
 Why?
Erythrocytes
1
2022
673
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
171
0.030
 Why?
Poverty Areas
1
2016
35
0.030
 Why?
Catheterization
1
1997
176
0.030
 Why?
Urban Health
1
2016
79
0.030
 Why?
Cardiac Catheterization
1
2000
519
0.030
 Why?
Rural Health
1
2016
71
0.030
 Why?
Chi-Square Distribution
1
2017
515
0.030
 Why?
Drug Discovery
1
2017
131
0.030
 Why?
Pharmacogenomic Variants
1
2016
35
0.030
 Why?
Tumor Cells, Cultured
1
1998
931
0.030
 Why?
Attitude of Health Personnel
1
2004
1102
0.030
 Why?
Internationality
1
2017
150
0.030
 Why?
Drug Industry
1
2017
105
0.030
 Why?
Albuminuria
1
2017
183
0.030
 Why?
Cognitive Dysfunction
1
2021
347
0.030
 Why?
Membrane Proteins
1
2022
1118
0.030
 Why?
Body Mass Index
1
2024
2269
0.030
 Why?
Troponin
2
2007
50
0.030
 Why?
Fatty Acids
1
1998
427
0.030
 Why?
Immunoglobulin M
2
2009
276
0.030
 Why?
Genome-Wide Association Study
1
2022
1326
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
140
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Quality of Life
1
2007
2694
0.030
 Why?
Physicians
1
2004
872
0.030
 Why?
Creatinine
1
2017
489
0.030
 Why?
Receptors, LDL
1
2015
46
0.030
 Why?
Thrombolytic Therapy
1
1996
137
0.030
 Why?
Lidocaine
1
1994
41
0.030
 Why?
Myositis
1
2015
51
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
376
0.030
 Why?
Social Class
1
2016
258
0.030
 Why?
Adenosine
2
1994
225
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
90
0.030
 Why?
Electric Stimulation
1
1995
269
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
28
0.030
 Why?
Osmolar Concentration
1
1994
167
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
127
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
133
0.030
 Why?
Analysis of Variance
1
2017
1286
0.030
 Why?
Stroke Volume
1
1997
593
0.030
 Why?
Adenosine Diphosphate
1
1994
78
0.030
 Why?
NAD
1
1994
74
0.030
 Why?
Hyperglycemia
1
2017
325
0.030
 Why?
Glycine
1
1994
166
0.030
 Why?
Mitochondria, Heart
1
1994
94
0.030
 Why?
Patient Outcome Assessment
1
2014
126
0.030
 Why?
Glomerular Filtration Rate
1
2017
711
0.030
 Why?
Perioperative Period
1
2013
52
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
37
0.030
 Why?
Oxidative Phosphorylation
1
1994
187
0.030
 Why?
Immunoglobulin G
2
2009
851
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
133
0.020
 Why?
Heparin
1
1994
253
0.020
 Why?
Dogs
3
1984
385
0.020
 Why?
Actinin
1
2012
13
0.020
 Why?
South Africa
1
2013
193
0.020
 Why?
Socioeconomic Factors
1
2016
1211
0.020
 Why?
Weight Gain
1
2016
510
0.020
 Why?
Patient Selection
1
1996
659
0.020
 Why?
Mathematics
1
1992
103
0.020
 Why?
Cardiac Output, Low
1
1992
66
0.020
 Why?
Perfusion
1
1992
197
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
338
0.020
 Why?
Vascular Resistance
2
1984
369
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
381
0.020
 Why?
Reperfusion
1
1991
38
0.020
 Why?
Biopsy
1
1995
1087
0.020
 Why?
Disease-Free Survival
1
2013
647
0.020
 Why?
Anticoagulants
1
1996
637
0.020
 Why?
Poisson Distribution
1
2011
73
0.020
 Why?
Georgia
1
2011
80
0.020
 Why?
Constriction
1
1990
46
0.020
 Why?
Vitamin D-Binding Protein
1
1990
15
0.020
 Why?
Patient Discharge
1
2017
854
0.020
 Why?
Cells, Cultured
1
1998
4087
0.020
 Why?
Alleles
1
2013
843
0.020
 Why?
Equipment Design
1
1992
514
0.020
 Why?
Hypoglycemia
1
2015
424
0.020
 Why?
Regression Analysis
1
1992
994
0.020
 Why?
Cognition Disorders
1
2014
505
0.020
 Why?
Autoantibodies
2
2009
1468
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2062
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
82
0.020
 Why?
Mice
2
2016
16973
0.020
 Why?
Environmental Exposure
1
1992
463
0.020
 Why?
Educational Status
1
2011
469
0.020
 Why?
Thromboembolism
1
2009
112
0.020
 Why?
Densitometry
1
2007
34
0.020
 Why?
Spectrin
1
2007
13
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
37
0.020
 Why?
Databases, Factual
1
2013
1261
0.020
 Why?
Poverty
1
2011
497
0.020
 Why?
Heart Diseases
1
1990
349
0.020
 Why?
Kidney
1
2014
1382
0.020
 Why?
Calcium-Binding Proteins
1
2007
212
0.020
 Why?
ROC Curve
1
2007
503
0.020
 Why?
Fatal Outcome
1
2006
300
0.010
 Why?
Protein Processing, Post-Translational
1
2007
456
0.010
 Why?
Apolipoprotein B-100
1
2004
10
0.010
 Why?
Aminophylline
1
1984
10
0.010
 Why?
Vasomotor System
1
1984
44
0.010
 Why?
Solubility
1
2004
232
0.010
 Why?
Health Care Surveys
1
2004
557
0.010
 Why?
Immunohistochemistry
1
2006
1684
0.010
 Why?
Odds Ratio
1
2004
1018
0.010
 Why?
Electrophysiology
1
1982
213
0.010
 Why?
Echocardiography
2
1997
635
0.010
 Why?
Vascular Surgical Procedures
1
2004
295
0.010
 Why?
Young Adult
1
2016
12438
0.010
 Why?
Cross-Sectional Studies
1
2011
5078
0.010
 Why?
Adolescent
2
2016
20409
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
539
0.010
 Why?
Thorax
1
1997
45
0.010
 Why?
Phosphorus Isotopes
1
1995
7
0.010
 Why?
Infusions, Parenteral
1
1994
37
0.010
 Why?
Basal Metabolism
1
1994
58
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
86
0.010
 Why?
T-Lymphocytes
1
2002
1935
0.010
 Why?
Substrate Specificity
1
1995
371
0.010
 Why?
Lung
1
2006
3928
0.010
 Why?
Glycolysis
1
1995
313
0.010
 Why?
Stimulation, Chemical
1
1992
65
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2393
0.010
 Why?
Diphosphoglyceric Acids
1
1991
4
0.010
 Why?
Radio Waves
1
1991
17
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Cardiomegaly
1
1990
170
0.000
 Why?
Rats
1
1997
5470
0.000
 Why?
Heart Block
1
1984
40
0.000
 Why?
Theophylline
1
1984
68
0.000
 Why?
Oxygen
1
1984
914
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3392
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (518) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)